Clinical Trial Update: Exposure Chamber Trial With Cat Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 exposure chamber trial of cat allergen immunotherapy completed, evaluating its effects for cat allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy

Drugs mentioned

• Cat allergen immunotherapy (cat dander allergen extract)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Cat Allergy | Phase 2 | Status: COMPLETED